| Nichols, Linda Olivia |
| Active, not recruiting | N/A | 110 | US | REACH Hope | Memphis VA Medical Center, Virginia Commonwealth University, University of Tennessee | Dementia, Mixed, Dementia of Alzheimer Type, TBI (Traumatic Brain Injury) | 08/23 | 08/23 | | |
| Unruh, Mark |
| Completed | 2 | 643 | US | Pain Coping Skills Training (PCST), Buprenorphine | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Hennepin Health Care, New York University, Massachusetts General Hospital, University of Illinois at Chicago, University of Pittsburgh, University of Washington, University of New Mexico, Rogosin Institute, Vanderbilt University Medical Center, West Virginia University, Yale University, Durham VA Health Care System, VA Portland Healthcare System, West Haven VA Medical Center, University of Pennsylvania, Dallas VA Medical Center, VA New York Harbor Healthcare System | End Stage Renal Disease, Chronic Pain, Opioid Dependence | 12/23 | 05/24 | | |
| Recruiting | N/A | 500 | US | | University of New Mexico | Diabetes Mellitus, Chronic Kidney Diseases, Heart Diseases, Cardiovascular Diseases | 04/25 | 06/25 | | |
| Recruiting | N/A | 600 | US | Advance Care Planning Video Decision Aid | Tufts Medical Center, National Institute on Aging (NIA) | Renal Disease, End Stage, Palliative Care, Decision Aids | 12/25 | 12/25 | | |
| Recruiting | N/A | 252 | US | Twice-weekly hemodialysis with incremental crossover to thrice-weekly schedule, Thrice-Weekly Hemodialysis | VA Office of Research and Development | Chronic Kidney Disease (CKD) Stage 5, Kidney Dysfunction Requiring Dialysis (KDRD), Dialysis Dependency | 09/27 | 09/27 | | |
| Kovesdy, Csaba P |
NCT06123195: Effects of Constipation Treatment in Chronic Kidney Disease: A Pilot Feasibility Trial |
|
|
| Recruiting | N/A | 40 | US | Constipation treatment | University of Tennessee, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Florida | Chronic Kidney Disease, Constipation | 06/25 | 07/25 | | |
| Recruiting | N/A | 252 | US | Twice-weekly hemodialysis with incremental crossover to thrice-weekly schedule, Thrice-Weekly Hemodialysis | VA Office of Research and Development | Chronic Kidney Disease (CKD) Stage 5, Kidney Dysfunction Requiring Dialysis (KDRD), Dialysis Dependency | 09/27 | 09/27 | | |
| Zhou, QiQi |
| Recruiting | N/A | 80 | US | Oral Glutamine, Control Arm | VA Office of Research and Development | Gulf War Illness, Irritable Bowel Syndrome, Gastrointestinal Symptoms | 07/26 | 07/27 | | |
| Wall, Barry M |
| Recruiting | 4 | 2510 | US | Pentoxifylline, Placebo | VA Office of Research and Development | Diabetic Kidney Disease | 01/28 | 07/30 | | |
| Weir, Alva B |
NCT04305444: Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas |
|
|
| Recruiting | 2 | 120 | US | DTRM-555, DTRMWXHS-12, everolimus, pomalidomide | Zhejiang DTRM Biopharma | Relapsed Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Richter's Transformation | 03/24 | 03/24 | | |
| Recruiting | 2 | 51 | US | High dose testosterone, Bipolar androgen therapy | VA Office of Research and Development | Metastatic Prostate Cancer | 08/26 | 08/27 | | |
| Recruiting | N/A | 5000 | Europe, Canada, US, RoW | Standard of Care | Prostate Cancer Clinical Trials Consortium | Prostate Cancer | 01/29 | 01/29 | | |
| Fiotto, Jade |
| Recruiting | 3 | 2540 | US | Metoprolol Succinate, Carvedilol | VA Office of Research and Development | End-Stage Kidney Disease, End-Stage Renal Disease | 11/25 | 12/27 | | |
| Verne, George |
| Recruiting | N/A | 80 | US | Oral Glutamine, Control Arm | VA Office of Research and Development | Gulf War Illness, Irritable Bowel Syndrome, Gastrointestinal Symptoms | 07/26 | 07/27 | | |
| Cushman, William C |
| Completed | 3 | 295 | Europe, US, RoW | Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg, Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg, Placebo | George Medicines PTY Limited | Hypertension | 09/23 | 10/23 | | |
GMRx2_ACT, NCT04518293: Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension |
|
|
| Completed | 3 | 1385 | Europe, US, RoW | Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg, telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg, Telmisartan 20 mg/amlodipine 2.5 mg ., telmisartan 40 mg/amlodipine 5 mg, Telmisartan 20 mg/indapamide 1.25 mg, telmisartan 40 mg/indapamide 2.5 mg, Amlodipine 2.5 mg/indapamide 1.25 mg, amlodipine 5 mg/indapamide 2.5 mg | George Medicines PTY Limited | Hypertension | 08/23 | 09/23 | | |
| Childress, Richard |
| Recruiting | 4 | 20000 | US | Atorvastatin 40 Mg Oral Tablet, Lipitor, Placebo oral tablet | Duke University, National Institute on Aging (NIA), National Heart, Lung, and Blood Institute (NHLBI), Wake Forest University Health Sciences | Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases | 12/26 | 12/26 | | |
| Recruiting | 4 | 7410 | US | Metformin XR, Placebo | VA Office of Research and Development | Prediabetic State, Atherosclerosis, Metformin | 03/29 | 03/29 | | |
| Waring, Ashley |
| Recruiting | 4 | 7410 | US | Metformin XR, Placebo | VA Office of Research and Development | Prediabetic State, Atherosclerosis, Metformin | 03/29 | 03/29 | | |
| Theus, Sue A |
| Recruiting | N/A | 80 | US | Oral Glutamine, Control Arm | VA Office of Research and Development | Gulf War Illness, Irritable Bowel Syndrome, Gastrointestinal Symptoms | 07/26 | 07/27 | | |
| Wagner, Brent |
| Recruiting | 4 | 2510 | US | Pentoxifylline, Placebo | VA Office of Research and Development | Diabetic Kidney Disease | 01/28 | 07/30 | | |
